Cargando…

PEAK1, a Novel Kinase Target in the Fight Against Cancer

Detalles Bibliográficos
Autores principales: Kelber, Jonathan A., Klemke, Richard L.
Formato: Texto
Lenguaje:English
Publicado: Impact Journals LLC 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057678/
https://www.ncbi.nlm.nih.gov/pubmed/21301050
_version_ 1782200300272091136
author Kelber, Jonathan A.
Klemke, Richard L.
author_facet Kelber, Jonathan A.
Klemke, Richard L.
author_sort Kelber, Jonathan A.
collection PubMed
description
format Text
id pubmed-3057678
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-30576782011-03-15 PEAK1, a Novel Kinase Target in the Fight Against Cancer Kelber, Jonathan A. Klemke, Richard L. Oncotarget Research Perspectives Impact Journals LLC 2010-07-08 /pmc/articles/PMC3057678/ /pubmed/21301050 Text en Copyright: © 2010 Kelber and Klemke http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
spellingShingle Research Perspectives
Kelber, Jonathan A.
Klemke, Richard L.
PEAK1, a Novel Kinase Target in the Fight Against Cancer
title PEAK1, a Novel Kinase Target in the Fight Against Cancer
title_full PEAK1, a Novel Kinase Target in the Fight Against Cancer
title_fullStr PEAK1, a Novel Kinase Target in the Fight Against Cancer
title_full_unstemmed PEAK1, a Novel Kinase Target in the Fight Against Cancer
title_short PEAK1, a Novel Kinase Target in the Fight Against Cancer
title_sort peak1, a novel kinase target in the fight against cancer
topic Research Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057678/
https://www.ncbi.nlm.nih.gov/pubmed/21301050
work_keys_str_mv AT kelberjonathana peak1anovelkinasetargetinthefightagainstcancer
AT klemkerichardl peak1anovelkinasetargetinthefightagainstcancer